Which colon cancer surgery is best? new study aims to find out
NCT ID NCT06329102
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tracks 1,000 people with right-sided colon cancer to compare standard surgery versus more extensive lymph node removal. Researchers will look at complications, recovery, and long-term survival. The goal is to find the best balance between removing enough tissue and avoiding side effects.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help determine the best surgical approach for right-sided colon cancer, potentially improving survival and reducing complications.
- What could go wrong
- This is an observational study, not a controlled trial, so results may show associations but not prove cause and effect. Differences between techniques may be small and hard to detect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2021
- Expected to finish
-
Sep 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients with confirmed adenocarcinom of the right colon admitted to the hospital
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with malignant tumor of the right colon at CT and/or colonoscopy. * Confirmed adenocarcinoma * Patients medically cleared by anesthesiologist for general anesthesia and oncological radical resection * Informed consent Exclusion Criteria: * Patients under 18 years * Patients with recurrent cancer after previous surgery * Patients with ongoing treatment due to other cancer
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lymphadenectomy are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Haukeland University Hospital
RECRUITINGBergen, 5009, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dye-Guided surgery may spare healthy lymph nodes in esophageal cancer
- Laparoscopic vs open surgery: which is better for colon cancer recovery?
- Robot-Assisted colon surgery: a new tool under the microscope
- Could a simpler surgery be safer for aggressive uterine cancer?
- Keyhole surgery vs open surgery for colon cancer: which is better?
- Robot vs. scalpel: which colon surgery is better?